Lori A. Worley

7.1k citations

23 papers · 4.2k indexed · 4 hit papers · h-index 21

Co-authors: J. William Harbour Michael D. Onken A. Bowcock Justis P. Ehlers Elisha Roberson Shenghui Duan Katie A. Matatall Cynthia Helms
Topics: Ocular Oncology and Treatments (19 papers)Immunotherapy and Immune Responses (8 papers)Retinal Development and Disorders (5 papers)
Cited by: Ophthalmology Oncology Immunology
Journals: Science Journal of Biological Chemistry Nature Genetics
Partner nations: United States Russia Japan

In The Last Decade

Lori A. Worley

23 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas

2010 1.0k citations J. William Harbour, Michael D. Onken et al. Science profile →
Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death

2004 514 citations Michael D. Onken, Lori A. Worley et al. Cancer Research profile →
Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis

2013 479 citations Dominic E. Sanford, Brian A. Belt et al. Clinical Cancer Research profile →
Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma

2013 374 citations J. William Harbour, Elisha Roberson et al. Nature Genetics profile →

Peers

Countries citing papers authored by Lori A. Worley

Since Specialization

Citations

This map shows the geographic impact of Lori A. Worley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori A. Worley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori A. Worley more than expected).

Fields of papers citing papers by Lori A. Worley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori A. Worley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori A. Worley. The network helps show where Lori A. Worley may publish in the future.

Co-authorship network of co-authors of Lori A. Worley

This figure shows the co-authorship network connecting the top 25 collaborators of Lori A. Worley. A scholar is included among the top collaborators of Lori A. Worley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori A. Worley. Lori A. Worley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Epidurals in Pancreatic Resection Outcomes (E-PRO) study: protocol for a randomised controlled trial 2018 ·BMJ Open ·Linda M. Pak,Simon Haroutounian,William G. Hawkins,Lori A. Worley,(unknown),Karen Frey,Μενέλαος Καρανικόλας,Robert A. Swarm,Michael M. Bottros	3
2	Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer 2014 ·Cancer Immunology Immunotherapy ·Roheena Z. Panni,Dominic E. Sanford,Brian A. Belt,Jonathan B. Mitchem,Lori A. Worley,Brian D. Goetz,Pinku Mukherjee,Andrea Wang‐Gillam,Daniel C. Link,David G. DeNardo,S. Peter Goedegebuure,David C. Linehan	173
3	Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axisbreakdown → 2013 ·Clinical Cancer Research ·Dominic E. Sanford,Brian A. Belt,Roheena Z. Panni,Allese Mayer,Anjali D. Deshpande,Danielle Carpenter,Jonathan B. Mitchem,Stacey M. Plambeck-Suess,Lori A. Worley,Brian D. Goetz,Andrea Wang‐Gillam,Timothy J. Eberlein,David G. DeNardo,S. Peter Goedegebuure,David C. Linehan	479
4	Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanomabreakdown → 2013 ·Nature Genetics ·J. William Harbour,Elisha Roberson,Hima Anbunathan,Michael D. Onken,Lori A. Worley,A. Bowcock	374
5	BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma 2013 ·BMC Cancer ·Katie A. Matatall,Olga A. Agapova,Michael D. Onken,Lori A. Worley,A. Bowcock,J. William Harbour	112
6	An Accurate, Clinically Feasible Multi-Gene Expression Assay for Predicting Metastasis in Uveal Melanoma 2010 ·Journal of Molecular Diagnostics ·Michael D. Onken,Lori A. Worley,(unknown),J. William Harbour	243
7	Association between Gene Expression Profile, Proliferation and Metastasis in Uveal Melanoma 2010 ·Current Eye Research ·Michael D. Onken,Lori A. Worley,J. William Harbour	26
8	Frequent Mutation of BAP1 in Metastasizing Uveal Melanomasbreakdown → 2010 ·Science ·J. William Harbour,Michael D. Onken,Elisha Roberson,Shenghui Duan,Li Cao,Lori A. Worley,Katie A. Matatall,Cynthia Helms,A. Bowcock	1024
9	Integrative Genomic Analysis of Aneuploidy in Uveal Melanoma 2008 ·Clinical Cancer Research ·Justis P. Ehlers,Lori A. Worley,Michael D. Onken,J. William Harbour	87
10	Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling 2008 ·Melanoma Research ·Lori A. Worley,(unknown),Michael D. Onken,J. William Harbour	126
11	Oncogenic Mutations in GNAQ Occur Early in Uveal Melanoma 2008 ·Investigative Ophthalmology & Visual Science ·Michael D. Onken,Lori A. Worley,(unknown),Shenghui Duan,A. Bowcock,J. William Harbour	258
12	Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis 2008 ·Melanoma Research ·Shu-Hong Chang,Lori A. Worley,Michael D. Onken,J. William Harbour	93
13	Transcriptomic versus Chromosomal Prognostic Markers and Clinical Outcome in Uveal Melanoma 2007 ·Clinical Cancer Research ·Lori A. Worley,Michael D. Onken,(unknown),(unknown),(unknown),Devron H. Char,Arie Perry,J. William Harbour	124
14	Loss of Heterozygosity of Chromosome 3 Detected with Single Nucleotide Polymorphisms Is Superior to Monosomy 3 for Predicting Metastasis in Uveal Melanoma 2007 ·Clinical Cancer Research ·Michael D. Onken,Lori A. Worley,(unknown),Devron H. Char,A. Bowcock,J. William Harbour	95
15	Functional Gene Expression Analysis Uncovers Phenotypic Switch in Aggressive Uveal Melanomas 2006 ·Cancer Research ·Michael D. Onken,Justis P. Ehlers,Lori A. Worley,(unknown),Yoshifumi Yokota,J. William Harbour	130
16	Prognostic Testing in Uveal Melanoma by Transcriptomic Profiling of Fine Needle Biopsy Specimens 2006 ·Journal of Molecular Diagnostics ·Michael D. Onken,Lori A. Worley,Rosa M. Dávila,Devron H. Char,J. William Harbour	52
17	Association Between Microarray Gene Expression Signature and Extravascular Matrix Patterns in Primary Uveal Melanomas 2005 ·American Journal of Ophthalmology ·Michael D. Onken,Amy Lin,Lori A. Worley,Robert Folberg,J. William Harbour	36
18	Loss of Rb-E2F Repression Results in Caspase-8-mediated Apoptosis through Inactivation of Focal Adhesion Kinase 2005 ·Journal of Biological Chemistry ·(unknown),Lori A. Worley,J. William Harbour	17
19	Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Deathbreakdown → 2004 ·Cancer Research ·Michael D. Onken,Lori A. Worley,Justis P. Ehlers,J. William Harbour	514
20	Altered expression of rb and p53 in uveal melanomas following plaque radiotherapy 2002 ·American Journal of Ophthalmology ·Milam A. Brantley,Lori A. Worley,J. William Harbour	21

About Lori A. Worley

Lori A. Worley is a scholar working on Ophthalmology, Immunology and Allergy and Immunology, having authored 23 papers that have together received 4.2k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (19 papers), Immunotherapy and Immune Responses (8 papers) and Retinal Development and Disorders (5 papers). The work is most often cited by research in Ophthalmology (2.5k citations), Oncology (1.8k citations) and Immunology (1.3k citations). Lori A. Worley has collaborated with scholars based in United States, Russia and Japan. Frequent co-authors include J. William Harbour, Michael D. Onken, A. Bowcock, Justis P. Ehlers, Elisha Roberson, Shenghui Duan, Katie A. Matatall, Cynthia Helms, Li Cao and Hima Anbunathan. Their work appears in journals such as Science, Journal of Biological Chemistry and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact